Reneo shareholders elect Dube and Hoelscher as Class I directors, ratify Ernst & Young as auditor

OnKure Therapeutics, Inc.

Annual Meeting held June 1, 2022; total outstanding shares 24,458,550.
Eric M. Dube elected with 18,100,489 votes for, 795,195 against, 2,790,889 broker non-votes.
Paul W. Hoelscher elected with 18,877,021 votes for, 18,663 against, 2,790,889 broker non-votes.
Ratification of Ernst & Young as independent auditor for fiscal 2022 approved (21,675,242 for, 11,300 against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.